|
RU2630302C1
|
|
Method for purification of recombinant protein containing myelopeptides sequences
|
|
RU2620170C1
|
|
Application of cationic peptides for human melanoma cells death induction
|
|
RU2622003C1
|
|
Method to assess hypersensitivity to histamine release from whole blood leukocytes
|
|
RU2609839C1
|
|
Method of differential diagnostics of hypersensitivity to bee poison (apis mellifera)
|
|
RU2611393C1
|
|
Method of diagnostics of thymomegaly in children
|
|
RU2611402C1
|
|
Prognosis method of development of allergic rhinitis
|
|
RU2613892C1
|
|
Method for prediction the chronic recurrent aphthous stomatitis character by mucosal immunity assessment
|
|
RU2615463C1
|
|
Method for allergic bronchial asthma treatment, based on cytokines il-4 and il-13 genes expression inhibition using sirna molecules
|
|
RU2611399C1
|
|
Labelled dendrimer peptides
|
|
RU2623639C2
|
|
Device for laboratory animals sitting and fixation
|
|
RU2614706C1
|
|
Generator of dry aerosols
|
|
RU2609857C1
|
|
Application of composition consisting of cationic ltp peptide and molecules of rna against respiratory viruses
|
|
RU2630561C2
|
|
Method for production of fullerene water-salt dispersions
|
|
RU2614123C1
|
|
Method for producing a complex shigellosis drug
|
|
RU2614264C2
|
|
Optimized recombinant protein encoding gene - human interferon beta analog
|
|
RU2620073C2
|
|
Optimized recombinant protein encoding gene - human interferon alpha-17 analog
|
|
RU2601126C2
|
|
Method of producing biologically active peptides
|
